Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Acist Medical Systems — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

90 daysmedian FDA review time
426 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K132474CARDIOVASCULAR PRESSURE MEASUREMENT (CPM) SYSTEM, NAVVUS CATAcist Medical Systems2014-01-301760
K020892ACIST GENTOO CONTRAST INJECTION SYSTEMAcist Medical Systems2003-01-273140
K021015ACIST PLUS 4 ANGIOGRAPHIC CATHETERAcist Medical Systems2002-04-26280
K991103MODIFICATION TO ACIST CL 100HAcist Medical Systems2000-05-314263
K000013ACIST ANGIOGRAPHIC INJECTION SYSTEM, MODEL R-2000Acist Medical Systems2000-03-28850
K993774ACIST ANGIOGRAPHIC INJECTION SYSTEM, MODEL CL1OOHAcist Medical Systems1999-12-07290
K984058ACIST INJECTOR SYSTEM, MODEL CL100 HAcist Medical Systems1999-02-11900

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda